Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee

NCT ID: NCT06423378

Last Updated: 2025-03-28

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: PHASE2
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-03-05
• Study Completion Date: 2026-12-05

Brief Summary

The OSSIOfiber® Trimmable Fixation Nails are indicated for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts in the presence of appropriate additional immobilization (e.g., rigid fixation implants, cast, brace). Our hypothesis is that the use of OSSIOfiber® Trimmable Fixation Nails for treating subchondral insufficiency of the knee will result in improvement of patient-reported outcomes and imaging findings. The primary objective of this study is to evaluate the effectiveness of implanting bio-integrative OSSIOfiber® Trimmable Fixation Nails, organized in a bi-cortical rafter formation within the tibia or femur for the management of subchondral insufficiency. The OSSIOfiber® Trimmable Fixation Nails used in this study will be considered on-label.

Conditions

Subchondral Insufficiency Fracture

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Interventions

OSSIOfiber® Trimmable Fixation Nails

Subjects will be treated with cannulated nails before or after arthroscopic management of their concomitant pathology at the discretion of the investigator. Technique described below. Following nail placement, tissue layers will be closed in standard fashion.

1. Preop MRI views used to estimate the proper depth & location of nail placement on the femur and/or tibia

2. Exposure is gained to medial tibia

3. 1.4 mm K-Wire is placed through medial tibia parallel to the articular joint surface ~ 1 cm distal to the articular joint line

4. A depth gauge is placed over K-Wire to determine required length of cannulated nail

5. A 4.0 mm cannulated drill bit used over K-Wire to prepare the pilot hole

6. Tamp is used to insert pre-trimmed 4.0 mm cannulated nail into the pilot hole and K-Wire is subsequently removed

7. Intraop fluoroscopy can confirm adequate nail placement prior to removing K-wire

8. Repeat steps for additional nails

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Agree to study participation and consent obtained.
• Able to attend all postoperative clinical visits, undergo imaging procedures, and complete relevant questionnaires.
• Subjects between the ages of 18 to 75 years.
• Body Mass Index < 40.
• Has knee pain in the study knee lasting at least 3 months and has had at least moderate pain recorded on a standard of care (SOC) preoperative Knee Injury and Osteoarthritis Outcome Score (KOOS) and/or Numeric Pain Reported Scale (0-10) questionnaire. The study team may utilize these verbal pain scores collected during the clinic intake process for screening purposes. If the patient was not administered the verbal pain score, the patient will be consented, administered the pain survey, and withdrawn if moderate pain score was not recorded.
• At least 3-months without steroid injection or any other non-surgical intervention administered to study knee.
• Candidate for knee arthroscopy due to meniscal tear, loose body, unstable articular cartilage or mechanical symptoms.
• Uni-compartmental Kellgren-Lawrence grade 2-3 osteoarthritis in the study tibia or femur.
• Bone Marrow Lesion (BML) confirmed on magnetic resonance imaging in the femur, tibia or both.
• Cartilage lesion on the tibial or femoral condyle(s) of a grading ≤4 by either the International Cartilage Repair Society or Outerbridge classifications verified at the time of arthroscopy.

Exclusion Criteria

• Imaging evidence of the study knee that includes any of the following:

1. Kellgren-Lawrence grade 4 osteoarthritis.

2. Collapse of subchondral bone.

3. Avascular Necrosis (AVN).

4. Osteochondral defect overlying the BML

5. BML located at ACL or PCL insertions

• Clinical evidence of the study knee that includes any of the following:

1. History of rheumatoid arthritis, septic arthritis, reactive arthritis, gout or pseudogout, secondary arthropathy (e.g., hemochromatosis, hemophilia, or psoriasis).

2. Osteochondritis dissecans.

3. Frank ligamentous instability.

4. Neuromuscular deficiency or other that would limit the ability to do a functional assessment.

• Bi-cortical nail implantation cannot be achieved, including where the required nail length is not yet available.
• Current tobacco use or has quit within 3 months of study enrolment.
• Substance abuse history.
• Diabetes mellitus, HbA1c>8
• High surgical risk due to pre-existing conditions.
• Currently pregnant or has plans to become pregnant prior to surgery.
• Active infection or history of chronic infection in study knee.
• Will require concomitant procedures within study knee, including but not limited to ligament reconstruction, tendon repair, meniscus repair, microfracture, osteotomy, or osteochondral transplantation (Meniscal tears, including chronic, are acceptable if no repair is required)
• Significant malalignment (varus or valgus) of the knee (>8°)
• Use of augmentation or concomitant biologic therapy during surgery.
• Contraindications to magnetic resonance imaging.
• Any condition which in the view of the treating physician makes it inadvisable for the subject to participate in the study.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Vanderbilt University Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Lance LeClere

Dr. Lance LeClere, MD; Principal Investigator, Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Lindsey Agnew, MS

Role: CONTACT

lindsey.agnew@vumc.org

6158751996

Facility Contacts

Lindsey Agnew, MS

Role: primary

lindsey.agnew@vumc.org

615-875-1996

Other Identifiers

OSSIOfiber Kneebar

Identifier Type: -

Identifier Source: org_study_id